UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Final Amendment)
KIRSCHNER MEDICAL CORPORATION
(Name of Issuer)
Common Stock, $.10 Par Value
(Title of Class of Securities)
497660 10 0
(CUSIP Number)
Daniel P. Hann, Biomet, Inc.
Airport Industrial Park, P.O. Box 587
Warsaw, Indiana 46580 (800) 348-9500
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 4, 1994
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule l3D, and is filing this
schedule because of Rule l3d-1(b)(3) or (4), check the following box __.
Check the following box if a fee is being paid with the statement __. (A fee
is not required only if the reporting person: (1) has a previous statement on
file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule l3d-l(a) for other parties to whom copies are to be
sent.
The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act
of 1934 ("Act") or otherwise subject to the liabilities of that section of the
Act but shall be subject to all other provisions of the Act (however, see the
Notes).
Total pages: ________
SCHEDULE 13D
CUSIP No. 497660 10 0 Page _________ of _________ Pages
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Biomet, Inc. 35-1480613
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ___
(b) _X_
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS
WC
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D)OR 2(E) ___
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
Not Applicable
- --------------------------------------------------------------------------------
8 SHARED VOTING POWER
Not Applicable
- --------------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
Not Applicable
- --------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
Not Applicable
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
Not Applicable
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES ___
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Not Applicable
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF
THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS)
OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
- --------------------------------------------------------------------------------
SCHEDULE 13D
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Kirschner Acquisition Corp. 35-1928713
- --------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ___
(b) _X_
- --------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------
4 SOURCE OF FUNDS
AF
- --------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS
REQUIRED PURSUANT TO ITEMS 2(D)OR 2(E) ___
- --------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OR ORGANIZATION
U.S.A.
- --------------------------------------------------------------------------------
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
- --------------------------------------------------------------------------------
7 SOLE VOTING POWER
Not Applicable
- --------------------------------------------------------------------------------
8 SHARED VOTING POWER
Not Applicable
- --------------------------------------------------------------------------------
9 SOLE DISPOSITIVE POWER
Not Applicable
- --------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
Not Applicable
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH
REPORTING PERSON
Not Applicable
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11)
EXCLUDES CERTAIN SHARES ___
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
Not Applicable
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- --------------------------------------------------------------------------------
SEE INSTRUCTIONS BEFORE FILLING OUT! INCLUDE BOTH SIDES OF
THE COVER PAGE, RESPONSES TO ITEMS 1-7 (INCLUDING EXHIBITS)
OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION.
- --------------------------------------------------------------------------------
Item 4. Purpose of Transaction
The merger of Kirschner Medical Corporation ("Kirschner")
with and into Kirschner Acquisition Corp. ("KAC"), a wholly-owned
subsidiary of the Biomet, Inc. ("Biomet"), pursuant to an
Agreement and Plan of Merger by and among Biomet, Kirschner and
Biomet Acquisition Corp. ("BAC"), dated July 16, 1994, which was
subsequently amended by a First Amendment to Agreement and Plan
of Merger by and among the Biomet, Kirschner, BAC and KAC, dated
September 15, 1994, was approved by a majority of the
shareholders of Kirschner and consummated on November 4, 1994.
The merger became effective at 12:01 a.m. on November 5, 1994
(the "Effective Time").
On November 4, 1994, Biomet delivered $16,245,980.50 and
1,384,309 Common Shares of Biomet to Bankers Trust Company, the
Exchange Agent (the "Merger Consideration"). At the Effective
Time, Kirschner was merged into KAC, which changed its name to
"Kirschner Medical Corporation."
On November 7, 1994, Kirschner filed Form 15 with the
Securities and Exchange Commission and the National Association
of Securities Dealers Automated Quotation System deregistering
Kirschner Common Stock under the Securities Exchange Act of 1934,
as amended.
Item 5. Interest in Securities of the Issuer
As a result of the Merger, all of the shares of Common Stock
of Kirschner outstanding immediately prior to the Merger were
converted into the Merger Consideration.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
BIOMET, INC.
Date: November 18, 1994 By: /s/ Gregory D. Hartman
________________________
Gregory D. Hartman
Vice President (Finance)
KIRSCHNER ACQUISITION CORP.
Date: November 18, 1994 By: /s/ Gregory D. Hartman
______________________
Gregory D. Hartman,
Treasurer
